News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

One Year Data From St. Jude Medical (STJ) Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction With EnligHTN Renal Denervation Technology



5/23/2013 10:50:45 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the company’s EnligHTN™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after one year. The new one year study data from the EnligHTN I trial was presented today at EuroPCR 2013 in Paris.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES